A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer
Cancer medicine, Volume 6, Issue 5, 2017, Pages 953-961.
ALKNSCLCclinicopathological characteristicscrizotinibreal-world study
Crizotinib has achieved astonishing success in advanced non-small-cell lung cancer (NSCLC) patients harboring anaplastic lymphoma kinase (ALK) rearrangement. However, no real-world studies described the clinicopathological characteristics and treatment of such patients in China. Patients were consecutively collected from Sun Yat-sen Unive...More
Full Text (Upload PDF)
PPT (Upload PPT)